Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GTXI

GTX (GTXI) Stock Price, News & Analysis

GTX logo

About GTX Stock (NASDAQ:GTXI)

Advanced Chart

Key Stats

Today's Range
$0.53
$0.53
50-Day Range
$1.20
$7.20
52-Week Range
$0.74
$25.60
Volume
N/A
Average Volume
390,540 shs
Market Capitalization
$12.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GTXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GTX and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GTXI Stock News Headlines

RX 6400 vs GTX 1060 - Test in 10 Games
FX 6300 Test in 8 Games (GTX 1060)
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.tc pixel
GTX 1660 Ti vs GTX 1060 Test in 8 Games
See More Headlines

GTXI Stock Analysis - Frequently Asked Questions

GTx, Inc. (NASDAQ:GTXI) posted its earnings results on Thursday, November, 15th. The biopharmaceutical company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.09.

Based on aggregate information from My MarketBeat watchlists, some other companies that GTX investors own include Corbus Pharmaceuticals (CRBP), Synergy Pharmaceuticals (SGYP), Novavax (NVAX), SELLAS Life Sciences Group (SLS), Verastem (VSTM), Bristol Myers Squibb (BMY) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/15/2018
Today
9/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:GTXI
CIK
1260990
Fax
N/A
Employees
21
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$38.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-104.19%
Return on Assets
-86.42%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.39
Quick Ratio
12.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.09 per share
Price / Book
0.48

Miscellaneous

Outstanding Shares
24,050,000
Free Float
N/A
Market Cap
$12.66 million
Optionable
Not Optionable
Beta
2.22
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:GTXI) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners